Global Study Reveals How Patients View Medical AI

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich (TUM) has investigated this for the first time in a large study spanning six continents. The central finding: the worse people rate their own health, the more likely they are to reject the use of AI. The study is intended to help align future medical AI applications more closely with patients’ needs.

Acceptance by patients is essential for the effective use of artificial intelligence in medicine, regardless of whether AI is used as a diagnostic tool, to create individual treatment plans or for other applications. The international research network of the COMFORT study therefore surveyed around 14,000 patients in 74 clinics in 43 countries. In order to cover a wide range of diseases, the survey was conducted in radiology departments that carry out X-ray, CT and MRI examinations on behalf of other specialist disciplines.

A majority - 57.6% - viewed the use of AI in medicine positively. However, some differences emerged within the cohort: men were slightly more favorable at 59.1% than women at 55.6%. Approval also rose markedly with greater familiarity with technology and higher self-rated understanding of AI. Among respondents who described themselves as highly knowledgeable about AI, 83.3% were positive about using it in medicine.

The more severe a person’s own illness, the more negative their attitude toward AI. More than half of patients in very poor health rated medical AI "extremely negative" or "rather negative" (26.6% and 29.2%, respectively). Among those in very good health, the corresponding figures were 1.3% and 5.3%.

"The exact reasons for negative attitudes among seriously ill patients cannot be determined from our study," says Dr. Felix Busch, assistant physician at TUM’s Institute of Diagnostic and Interventional Radiology and the study’s first author. "We suspect that experiences with the health care system, illness burden, and psychological factors play a role."

Respondents expressed clear preferences for how AI should be used and designed. For 70.2%, it was important that medical AI be ‘explainable,’ allowing users to see the steps leading to its conclusions. In addition, 72.9% wanted these technologies to function as tools, with physicians making the final decisions.

Only 4.4% favored diagnoses made exclusively by AI. At the same time, just 6.6% wanted diagnoses to be made entirely without AI. These questions referred to hypothetical scenarios in which human clinicians and AI were equally accurate. "The results show that explainability must be considered from the outset," says Felix Busch.

One methodological limitation is the survey timing in 2023. "Since then, large language models in particular have advanced considerably. Patient attitudes may have changed," says Adjunct Teaching Professor Dr. Keno Bressem, senior lecturer and, together with Adjunct Teaching Professor Dr. Lisa Adams, senior author of the study. "Follow-up surveys are needed to test this and to align the development of medical AI with patients’ needs," adds Dr. Lisa Adams. A follow-up study by the COMFORT consortium using the same questionnaire is already underway.

Busch F, Hoffmann L, Xu L, Zhang LJ, Hu B, García-Juárez I, Toapanta-Yanchapaxi LN, Gorelik N, Gorelik V, Rodriguez-Granillo GA, Ferrarotti C, Cuong NN, Thi CAP, Tuncel M, Kaya G, Solis-Barquero SM, Mendez Avila MC, Ivanova NG, Kitamura FC, Hayama KYI, Puntunet Bates ML, Torres PI, Ortiz-Prado E, Izquierdo-Condoy JS, Schwarz GM, Hofstaetter JG, Hide M, Takeda K, Peric B, Pilko G, Thulesius HO, Lindow T, Kolawole IK, Olatoke SA, Grzybowski A, Corlateanu A, Iaconi OS, Li T, Domitrz I, Kepczynska K, Mihalcin M, Fašaneková L, Zatonski T, Fulek K, Molnár A, Maihoub S, da Silva Gama ZA, Saba L, Sountoulides P, Makowski MR, Aerts HJWL, Adams LC, Bressem KK; COMFORT consortium; Navarro ÁA, Águas C, Aineseder M, Alomar M, Al Sliman R, Anand G, Angkurawaranon S, Aoki S, Arkoh S, Ashraf G, Astri Y, Bakhshi S, Bayramov NY, Billis A, Bitencourt AGV, Bolejko A, Bollas Becerra AJ, Bwambale J, Capela A, Cau R, Chacon-Acevedo KR, Chaunzwa TL, Chojniak R, Clements W, Cuocolo R, Dahlblom V, Sousa KM, Villarrubia JE, Desai VB, Dhakal AK, Dignum V, Andrade RGF, Ferraioli G, Ganguly S, Garg H, Savevska CG, Radovikj MG, Gkartzoni A, Gorospe L, Griffin I, Hadamitzky M, Ndahiro MH, Hering A, Hochhegger B, Huseynova MR, Ishida F, Jha N, Jiang L, Kader R, Kavnoudias H, Klein C, Kolostoumpis G, Koshy A, Kruger NA, Löser A, Lucijanic M, Mantziari D, Margue G, McFadden S, Miyake M, Morakote W, Ngabonziza I, Nguyen TT, Niehues SM, Nortje M, Palaian S, Pentara NV, de Almeida RPP, Poma G, Purwoko M, Pyrgidis N, Rafailidis V, Rainey C, Ribeiro JC, Agudelo NR, Sado K, Saidman JM, Saturno-Hernandez PJ, Suryadevara V, Schulz GB, Soric E, Soto-Pérez-Olivares J, Stanzione A, Struck JP, Takaoka H, Tanioka S, Huyen TTM, Truhn D, van Dijk EHC, van Wijngaarden P, Wang YC, Weidlich M, Zhang S.
Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients.
JAMA Netw Open. 2025 Jun 2;8(6):e2514452. doi: 10.1001/jamanetworkopen.2025.14452

Most Popular Now

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

International Study Reveals Sex and Age …

An international research team led by Assistant Professor Zhiyu Wan from ShanghaiTech University has recently published groundbreaking findings in the journal Health Data Science, highlighting biases in multimodal large language...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...